Local Anesthetic Response in Ehlers-Danlos Syndrome (EDS) and Healthy Volunteers
Condition(s) studied
Investigational drug(s) / intervention(s)
0.9% Sodium Chloride Injection: All participants will be injected subcutaneously with a single 0.5ml dose
Lidocaine Injection 2%: All participants will be injected subcutaneously with a single 0.5ml dose
Study summary
Local anesthetic resistance is commonly reported by patients with EDS. However, there are no objective data on the occurrence of local anesthetic resistance in EDS patients and in healthy volunteers. The investigators propose to collect such objective data on the frequency of drug resistance and whether any problems with local anesthesia are due to initial ineffectiveness or due to its effects dissipating too soon.
Eligibility
Primary outcome measure(s)
- Delta Pain Scores Lidocaine at 5 min [ Time Frame: 5 minutes post-injection ] — 5 minutes post-injection
Difference between the pain score at the Lidocaine injection locations (compared to a control location) and the saline injection location (compared to a control location). The pain scale is .a 4 level scale from 0 ("absent sensation"), to 1 ("dull pressure"), to 2 ("sharp but less than a control \[non-injected\] region) to 3 (same or worse than the control region).
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Cardiovascular Autonomic Research Lab, University of Calgary | Calgary | Alberta |
More University of Calgary trials in Canada
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05603741 on ClinicalTrials.gov ↗ ← All trials in Canada